Clinical trials
Vulvar Neoplasms trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Unknown status | 4 |
| Recruiting | 2 |
| Terminated | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Royal Marsden NHS Foundation Trust | 4 |
| CCTU- Cancer Theme | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Gloucestershire Hospitals NHS Foundation Trust | 1 |
| Imperial College London | 1 |
| Incyte Corporation | 1 |
| Institute of Cancer Research, United Kingdom | 1 |
| Royal Surrey County Hospital NHS Foundation Trust | 1 |
| The Christie NHS Foundation Trust | 1 |
| University Hospital Southampton NHS Foundation Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vulvar Neoplasms | 16 |
| Ovarian Neoplasms | 10 |
| Uterine Cervical Neoplasms | 10 |
| Endometrial Neoplasms | 9 |
| Vaginal Neoplasms | 9 |
| Fallopian Tube Neoplasms | 6 |
| Esophageal Neoplasms | 4 |
| Neoplasms | 4 |
| Sarcoma | 4 |
| Stomach Neoplasms | 4 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.